| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) | 
|---|
| 12/17/1998 | WO1998056818A1 Human l105 proteins and polynucleotides encoding same | 
| 12/17/1998 | WO1998056817A1 Composition and methods for the treatment of inflammatory diseases | 
| 12/17/1998 | WO1998056816A1 VACCINE COMPOSITIONS COMPRISING THE HELICOBACTER PYLORI FlgE POLYPEPTIDE | 
| 12/17/1998 | WO1998056815A1 VACCINE COMPOSITIONS COMPRISING THE HELICOBACTER PYLORI Pfr POLYPEPTIDE | 
| 12/17/1998 | WO1998056814A1 Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases | 
| 12/17/1998 | WO1998056813A2 Two human membrane-fusion proteins | 
| 12/17/1998 | WO1998056812A2 Estrogen receptor crystals and ligands | 
| 12/17/1998 | WO1998056811A2 Plant grab proteins | 
| 12/17/1998 | WO1998056810A2 Lus-1 human protein, its production and use | 
| 12/17/1998 | WO1998056806A1 A TRANSCRIPTION FACTOR COACTIVATOR PROTEIN, p/CIP | 
| 12/17/1998 | WO1998056805A1 Secreted proteins and polynucleotides encoding them | 
| 12/17/1998 | WO1998056804A1 86 human secreted proteins | 
| 12/17/1998 | WO1998056426A1 Controlled release microencapsulated ngf formulation | 
| 12/17/1998 | WO1998056421A1 Method for preventing hiv-1 infection of cd4+ cells | 
| 12/17/1998 | WO1998056417A1 Composition and method to prevent graft rejection and other counter-adaptive t lymphocyte mediated immune responses | 
| 12/17/1998 | WO1998056412A1 VACCINE COMPOSITIONS COMPRISING THE HELICOBACTER PYLORI 26kDa POLYPEPTIDE | 
| 12/17/1998 | WO1998056411A1 Novel antimicrobial polypeptide and methods of use | 
| 12/17/1998 | WO1998056404A1 Cns neuroregenerative compositions and methods of use | 
| 12/17/1998 | WO1998056401A1 Cd28/ctla-4 inhibiting peptidomimetics, pharmaceutical compositions thereof, and method of using same | 
| 12/17/1998 | WO1998056400A1 Anti-inflammatory and other therapeutic, prophylactic or diagnostic uses of synthetic melittin and new related peptides | 
| 12/17/1998 | WO1998056399A1 Type xviii collagen for detecting liver diseases | 
| 12/17/1998 | WO1998056248A1 A novel method of detecting and treating cancer | 
| 12/17/1998 | WO1998051325A3 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods | 
| 12/17/1998 | WO1998047917A3 A purified 20 kda presenilin 2 c-terminal fragment and methods of screening for compounds that inhibit proteolysis of presenilin 2 | 
| 12/17/1998 | WO1998046737A3 Cdna for human gdnf and promoter therefor which allows regulated and constitutive expression | 
| 12/17/1998 | WO1998045319A3 COMPOUNDS AND METHODS FOR INHIBITING THE INTERACTION BETWEEN α-CATENIN and β-CATENIN | 
| 12/17/1998 | WO1998044137A3 Plant pest control | 
| 12/17/1998 | WO1998041106A3 Frozen food product containing anti-freeze peptides | 
| 12/17/1998 | WO1998040401A3 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics | 
| 12/17/1998 | WO1998039467A3 Adenovirus vectors specific for cells expressing carcinoembryonic antigen and methods of use thereof | 
| 12/17/1998 | WO1998038209A3 Secreted proteins and polynucleotides encoding them | 
| 12/17/1998 | WO1998037093A3 Compounds for immunotherapy of prostate cancer and methods for their use | 
| 12/17/1998 | WO1998036084A3 Enhancing plant growth using genes encoding for carbonic anhydrase, calcium binding protein, metal binding protein or biomineralization protein | 
| 12/17/1998 | WO1998030586A3 Diagnostics and therapy of epstein-barr virus in autoimmune disorders | 
| 12/17/1998 | WO1998023759A3 Identification of inhibitors that prevent access of telomerase to chromosomal terminus | 
| 12/17/1998 | DE19725014A1 Aprotininvarianten mit verbesserten Eigenschaften und Bikunine von Aprotininvarianten Aprotinin variants with improved properties and Bikunine of aprotinin | 
| 12/17/1998 | CA2295991A1 Human tumor necrosis factor receptor tr9 | 
| 12/17/1998 | CA2295982A1 Human l105 proteins and polynucleotides encoding same | 
| 12/17/1998 | CA2294526A1 86 human secreted proteins | 
| 12/17/1998 | CA2294523A1 Method for preventing hiv-1 infection of cd4+ cells | 
| 12/17/1998 | CA2293825A1 Secreted proteins and polynucleotides encoding them | 
| 12/17/1998 | CA2293733A1 Mycardium-and skeletal muscle-specific nucleic acid, its preparation and use | 
| 12/17/1998 | CA2293722A1 Transgenic fish with tissue-specific expression | 
| 12/17/1998 | CA2293666A1 Cd28/ctla-4 inhibiting peptidomimetics, pharmaceutical compositions thereof, and method of using same | 
| 12/17/1998 | CA2293611A1 Methods for producing heterologous disulfide bond-containing polypeptides in bacterial cells | 
| 12/17/1998 | CA2293492A1 Cns neuroregenerative compositions and methods of use | 
| 12/17/1998 | CA2293363A1 Secreted proteins and polynucleotides encoding them | 
| 12/17/1998 | CA2293293A1 Vaccine compositions comprising the helicobacter pylori flge polypeptide | 
| 12/17/1998 | CA2293250A1 Human phosphatidylinositol transfer protein gamma | 
| 12/17/1998 | CA2292900A1 Live attenuated vaccines | 
| 12/17/1998 | CA2292788A1 Reagents and methods useful for detecting diseases of the lung | 
| 12/17/1998 | CA2292611A1 Estrogen receptor ligands | 
| 12/17/1998 | CA2292339A1 Smad6 and uses thereof | 
| 12/17/1998 | CA2291653A1 Protein elongation factor 2 as a target for antifungal and antiparasitic agents | 
| 12/17/1998 | CA2291338A1 Composition and method to prevent graft rejection and other counter-adaptive t lymphocyte mediated immune responses | 
| 12/17/1998 | CA2289863A1 Plant grab proteins | 
| 12/17/1998 | CA2289471A1 A novel method of detecting and treating cancer | 
| 12/17/1998 | CA2240005A1 Peptides acting as agonists and inhibitors of amyloid formation and cytotoxicity for therapeutic use with alzeheimer's disease, type ii diabetes mellitus and spongiform encephalopathies | 
| 12/16/1998 | EP0884388A1 Transgenic plants containing recombinant mistletoe lectin (rML) | 
| 12/16/1998 | EP0884387A2 Human 7-transmembrane receptor HLWAR77 | 
| 12/16/1998 | EP0884386A1 Sodium channel receptor | 
| 12/16/1998 | EP0884385A1 Intracellular modulators of apoptopic cell death pathways | 
| 12/16/1998 | EP0884329A1 Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof | 
| 12/16/1998 | EP0884328A1 Binding partners for collagen degradation peptides, and their use | 
| 12/16/1998 | EP0884327A1 Dendritic lysine-based polypeptides for targeted drug delivery | 
| 12/16/1998 | EP0884323A1 Renaturation of proteins by fluorinated reagents | 
| 12/16/1998 | EP0884055A1 Binding partners for collagen-derived peptide compositions, and their use | 
| 12/16/1998 | EP0884052A1 Cartilage/bone inducing materials for reparation | 
| 12/16/1998 | EP0883688A1 Adapter molecules for targeting viral particles to cells | 
| 12/16/1998 | EP0883687A2 C-c ckr-5, cc-chemikines receptor, derivatives thereof and their uses | 
| 12/16/1998 | EP0883626A1 Type ix collagen and fragments thereof | 
| 12/16/1998 | EP0883625A1 Novel platelet activation protein | 
| 12/16/1998 | EP0883602A2 Lipids and their use, for example, in liposomes | 
| 12/16/1998 | EP0883410A1 An osteogenic device and a method for preparing the device | 
| 12/16/1998 | EP0883344A1 Therapeutic molecules generated by trans-splicing | 
| 12/16/1998 | EP0763136B1 Method and probes for detecting markers bound to the locus of child spinal muscular atrophies | 
| 12/16/1998 | EP0731806A4 SPECIFIC FUSION NUCLEIC ACIDS AND PROTEINS PRESENT IN HUMAN t(2;5) LYMPHOMA, METHODS OF DETECTION AND USES THEREOF | 
| 12/16/1998 | EP0695190A4 Regulator regions of g proteins | 
| 12/16/1998 | EP0669934B1 Process for manufacturing crystals of growth hormone and crystals thereby obtained | 
| 12/16/1998 | EP0652962B1 Expression of recombinant fusion proteins in attenuated bacteria | 
| 12/16/1998 | EP0602064B1 Novel microorganism and insecticide | 
| 12/16/1998 | EP0575553B1 Recombinant hybrid porin epitopes | 
| 12/16/1998 | CN1202202A Juvenile hormone or one of its agonists as chemical ligang to control gene expression in plats by receptor mediated transactivation | 
| 12/16/1998 | CN1202201A Polyvalent anti-dengue vaccine | 
| 12/16/1998 | CN1202200A Fas ligang fusion protein | 
| 12/16/1998 | CN1202176A Heparin chromatography of erythropoietins | 
| 12/16/1998 | CN1202175A Mimotopes and anti-mimotopes of human platelet glycoprotein Ib/Ix | 
| 12/16/1998 | CN1041170C Bromelin decrustation preparation and its preparing method | 
| 12/16/1998 | CA2206774A1 "prionins", highly specific markers for noninvasive presymptomatic defection of tse diseases, and targets for therapeutic reagents to prevent and control tse diseases in animals and humans | 
| 12/15/1998 | US5850024 Reduction of endogenous seed protein levels in plants | 
| 12/15/1998 | US5850023 Modified plant viral replicase genes | 
| 12/15/1998 | US5850019 Promoter (FLt) for the full-length transcript of peanut chlorotic streak caulimovirus (PCLSV) and expression of chimeric genes in plants | 
| 12/15/1998 | US5850018 Expression control sequence for general and effective expression of genes in plants | 
| 12/15/1998 | US5850016 Alteration of amino acid compositions in seeds | 
| 12/15/1998 | US5850015 Hypersensitive response elicitor from Erwinia chrysanthemi | 
| 12/15/1998 | US5850014 Nucleotide sequences mediating ferility and method of using same | 
| 12/15/1998 | US5850003 Transgenic rodents harboring APP allele having swedish mutation | 
| 12/15/1998 | US5850002 Animal models for loss and gain of Hox11 function | 
| 12/15/1998 | US5850001 Transgenic mouse for the neuronal expression of HIV gp160 | 
| 12/15/1998 | US5850000 Transgenic non-human mammals comprising a bovine 5' flanking regulatory sequence |